"You signed a Management Services Organization (MSO) agreement thinking you were gaining a powerful private equity partner. But as state regulators aggressively crack down on Corporate Practice of Medicine (CPOM) laws in 2026, have you realized you are holding 100% of the clinical liability while the corporate board extracts 100% of the enterprise value?" The pitch from the Private Equity (PE) associate a few years ago was flawless: Sell your practice to our MSO, take a massive upfront...

"Your financial advisor just called to celebrate an 8% return in a generic S&P 500 index fund. Meanwhile, the surgeon in the OR next to you just captured a 30%+ internal rate of return by syndicating directly into an early-stage MedTech buyout. Why are you ignoring your ultimate insider advantage?" Walk into any premier wealth management firm in August 2026, and the playbook for a high-net-worth physician is remarkably predictable: maximize your W2 contributions, build a "diversified" 60/40...

Are you exporting high-margin spine cases, or capturing the facility fee with ASC-optimized technology? "Spine and interventional pain specialists are sitting on a massive, historically under-treated patient demographic. But if your facility's implant costs are too high, your ASC is simply functioning as a pass-through bank account for legacy MedTech." For decades, sacroiliac (SI) joint dysfunction, which accounts for up to 25% of all chronic lower back pain—was either chronically...